Travere Therapeutics, Inc.

Fisher Asset Management, LLC TVTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/9/2026

Shares

33,996

Value ($000)

1,299

Weight

0.0%

2020 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/9/2026	1,299	0.0%	33,996	12/31/2025
2025 Q3	11/12/2025	940	0.0%	39,341	9/30/2025
2025 Q2	8/13/2025	639	0.0%	43,182	6/30/2025
2025 Q1	5/14/2025	774	0.0%	43,182	3/31/2025
2024 Q4	2/5/2025	752	0.0%	43,182	12/31/2024
2024 Q3	11/12/2024	604	0.0%	43,182	9/30/2024
2024 Q2	8/14/2024	355	0.0%	43,182	6/30/2024
2024 Q1	5/9/2024	333	0.0%	43,182	3/31/2024
2023 Q4	3/5/2024	388	0.0%	43,182	12/31/2023
2023 Q3	11/13/2023	386	0.0%	43,182	9/30/2023
2023 Q2	12/12/2023	663	0.0%	43,182	6/30/2023
2023 Q1	12/12/2023	971	0.0%	43,182	3/31/2023
2022 Q4	2/3/2023	1,238	0.0%	58,873	12/31/2022
2022 Q3	11/8/2022	1,635	0.0%	66,362	9/30/2022
2022 Q2	8/9/2022	1,608	0.0%	66,362	6/30/2022
2022 Q1	5/5/2022	1,712	0.0%	66,445	3/31/2022
2021 Q4	2/2/2022	1,369	0.0%	44,118	12/31/2021
2021 Q3	10/26/2021	683	0.0%	28,180	9/30/2021
2021 Q2	7/27/2021	322	0.0%	22,070	6/30/2021
2021 Q1	4/27/2021	551	0.0%	22,070	3/31/2021
2020 Q4	1/29/2021	602	0.0%	22,070	12/31/2020